Comparison 8. Sensitivity analysis 4: EVS versus somatostatin, excluding the Escorsell's study.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Mortality | 4 | 237 | Risk Difference (M‐H, Random, 95% CI) | ‐0.06 [‐0.17, 0.05] |
1.1 Mortality | 4 | 237 | Risk Difference (M‐H, Random, 95% CI) | ‐0.06 [‐0.17, 0.05] |